Clinical Trials Search at Vanderbilt-Ingram Cancer Center

A Phase I/Ib Study Evaluating Single-Agent Inavolisib and Inavolisib Plus Atezolizumab in PIK3CA-Mutated Cancers

Multiple Cancer Types

Disease Sites: Head/Neck, Phase I

Phase: I

Investigator: Choe, Jennifer

NCTID:

Protocol No: VICCHNP22118

Clinical Trial Flowcharts
for Referring Physicians

Clinical Trial Flowcharts
for VICC Staff (VUNetID required)

Clinical Trials Search CTA Inline Referral Form